Igg4 Disease
Ceasing both immunosuppressants, glucocorticoids leads to IgG4-RD relapse in most patients
SAN DIEGO — Maintaining immunosuppression with or without low-dose glucocorticoids is superior to withdrawing both therapies in preventing relapses in IgG4-related disease, according to data presented at ACR Convergence 2023.
IgG4 may be ‘innocent bystander’ in IgG4 disease
DESTIN, Fla. — The role of IgG4 itself in IgG4 disease remains unclear, one of the many unexplained components of the condition, according to data presented at the Congress of Clinical Rheumatology East.
IgG4-related disease linked to increased risk for lymphoma, pancreatic cancer
Patients with IgG4-related disease are at a higher risk for cancer — particularly pancreatic and lymphoma — compared with the general population, according to a meta-analysis published in Arthritis Research & Therapy.
Despite better awareness, curative treatments remain elusive in IgG4 disease
Despite strong biomarkers and an improved understanding of the many systems involved in IgG4 disease, no curative therapy exists, according to a speaker at the virtual American College of Rheumatology State-of-the-Art Clinical Symposium.